A. Olsson

发表

Bleeding phenotype in carriers of haemophilia A does not correlate with thrombin generation

F. Baghaei, E. Berntorp, M. Holmström, 2015, Haemophilia.

Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B

R. Ljung, F. Baghaei, E. Berntorp, 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B – The MoHem study

J. Astermark, M. Bruzelius, G. Tjønnfjord, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Silent variant in F8:c.222G>T (p.Thr74Thr) causes a partial exon skipping in a patient with mild hemophilia A

R. Ljung, N. Andersson, A. Letelier, 2021, Molecular genetics & genomic medicine.

Quality of life, physical function and MRI T2* in elderly low‐risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions

J. Astermark, H. Garelius, L. Kjeldsen, 2011, European journal of haematology.

Reduced transforming growth factor‐β1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura

H. Wadenvik, P. Andersson, A. Olsson, 2002, British journal of haematology.

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

J. Astermark, L. Kjeldsen, O. Linder, 2008 .

Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy.

S. E. Jacobsen, J. Astermark, L. Kjeldsen, 2007 .

Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study

J. Astermark, M. Bruzelius, G. Tjønnfjord, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Real‐world prophylactic usage of recombinant factor IX Fc in Sweden: A report from the Swedish National Registry for bleeding disorders

Linda Myrin Westesson, J. Astermark, F. Baghaei, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Comparison of single subject and population‐based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A

A. Iorio, J. Astermark, P. Chelle, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Burden on parents of children with moderate or severe von Willebrand disease: The impact of clinical data

Linda Myrin Westesson, P. Petrini, A. Olsson, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Phenotype and genotype comparisons in carriers of haemophilia A

R. Ljung, F. Baghaei, E. Berntorp, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Real‐world prophylactic usage of recombinant factor VIII Fc in Sweden: A report from the Swedish national registry for bleeding disorders

J. Astermark, M. Holmström, M. Axelsson, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Acquired Haemophilia A in four north European countries: survey of 181 patients

R. Chaireti, T. Szanto, E. Zetterberg, 2022, British journal of haematology.

Association between bleeding tendency and health‐related quality of life in carriers of moderate and severe haemophilia

F. Baghaei, E. Berntorp, M. Hellgren, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Bleeding tendency and health-related quality of life in carriers of haemophilia

A. Olsson, Anna Olsson, 2016 .

Negative Effect of DNA Hypermethylation on the Outcome of Intensive Chemotherapy in Older Patients with High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia following Myelodysplastic Syndrome

J. Astermark, L. Kjeldsen, O. Linder, 2007, Clinical Cancer Research.

Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

J. Astermark, L. Kjeldsen, O. Linder, 2010, British journal of haematology.

Serum from patients with chronic idiopathic thrombocytopenic purpura frequently affect the platelet function.

L. Tengborn, H. Wadenvik, P. Andersson, 2002, Thrombosis research.

Platelet function testing: Current practice among clinical centres in Northern Europe

P. T. Onundarson, P. Holme, R. Lassila, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Association between bleeding tendency and health‐related quality of life in carriers of moderate and severe haemophilia

F. Baghaei, E. Berntorp, M. Hellgren, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.